Form 8-K - Current report:
SEC Accession No. 0001213900-25-056232
Filing Date
2025-06-20
Accepted
2025-06-20 16:30:11
Documents
13
Period of Report
2025-06-17
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246289-8k_180life.htm   iXBRL 8-K 34794
  Complete submission text file 0001213900-25-056232.txt   247225

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atnf-20250617.xsd EX-101.SCH 3798
3 XBRL DEFINITION FILE atnf-20250617_def.xml EX-101.DEF 26636
4 XBRL LABEL FILE atnf-20250617_lab.xml EX-101.LAB 36679
5 XBRL PRESENTATION FILE atnf-20250617_pre.xml EX-101.PRE 25260
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0246289-8k_180life_htm.xml XML 5820
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 251061822
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)